Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tranexamic acid (cyklokapron) (1 trial)
Osteoarthritis (Phase 2)
Trials (1 total)
Trial APIs (1 total)